drugset / Trial / NCT03675178

Clinical Study of Anerning Particle for the Treatment of Childhood Community-acquired Pneumonia

NCT03675178

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy, safety and whether it can reduction of antibiotic use in the treatment of community-acquired pneumonia in children with Anerning granules combined with ceftriaxone sodium.

Timeline

Start
2018-09-22
Primary completion
2019-06-30
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Background Ceftriaxone Other / unclassified 1 unknown
Background Ceftriaxone Other / unclassified 50 mg/kg Intravenous

Indications